Alejandro Molinos-Delgado
Santa Cruz De Tenerife, CN 38010, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease.
Journal: Biochemical pharmacology
Published: September 19, 2025
Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease.
Journal: Biochemical pharmacology
Published: September 19, 2025
FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease.
Journal: International journal of molecular sciences
Published: April 23, 2024
Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study.
Journal: Frontiers in endocrinology
Published: January 16, 2023
Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease.
Journal: Scientific reports
Published: February 16, 2022
Fibroblast growth factor 23 expression in human calcified vascular tissues.
Journal: Aging
Published: August 09, 2019
FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus.
Journal: Journal of clinical medicine
Published: February 26, 2019
Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease.
Journal: Clinical science (London, England : 1979)
Published: July 24, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026